Towards Kinase Inhibitor Therapies for Fragile X Syndrome: Tweaking Twists in the Autism Spectrum Kinase Signaling Network.

Cells · 2022 · PMC9029738 · PMID 35456004

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

For this reason, they also assessed levels of ERK1/2 phosphorylation in FXS subjects, which showed a trend towards higher phosphorylation but was not statistically significant, suggesting that ERK signaling is not the primary signaling pathway that is affected in the FXS [ 121 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.